Nautilus Biotechnology partners with the Institute for Translational Genomics Research to investigate applications of single-molecule proteomic analysis in diffuse intrinsic pontine gliomaBy Publishing TeamJanuary 20, 2023 Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, and the Institute for Translational…